Bristol-Myers Squibb Company (BVL:BMY)

Peru flag Peru · Delayed Price · Currency is PEN · Price in USD
53.86
+0.63 (1.18%)
At close: Jan 2, 2026
-5.59%
Market Cap363.28B
Revenue (ttm)166.54B
Net Income (ttm)20.94B
Shares Outn/a
EPS (ttm)10.30
PE Ratio17.35
Forward PE8.56
Dividend8.75 (16.25%)
Ex-Dividend DateJan 2, 2026
Volumen/a
Average Volume81
Openn/a
Previous Close53.23
Day's Rangen/a
52-Week Range42.38 - 59.85
Betan/a
RSI78.28
Earnings DateFeb 5, 2026

About BVL:BMY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Industry Pharmaceutical Preparations
Founded 1887
Employees 34,100
Stock Exchange Lima Stock Exchange
Ticker Symbol BMY
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.